Hearts and Minds Investments (HM1) is a unique listed investment company striving to deliver attractive equity investment returns for shareholders, while providing funding for Australian medical research. HM1 listed on the Australian Stock Exchange (ASX) on November 14, 2018. The HM1 portfolio is a mix of the the highest conviction ideas pitched by invitation at the SOHN Hearts and Minds annual conference, as well as via the six core managers, of which TDM is proud to be included.
HM1’s charitable goal is made possible by waiving typical investment fees and instead, making a sizeable donation to the suite of HM1 medical research beneficiaries. As such, TDM donates its proportion of the allocated 1.5% management fee via the TDM Foundation each year. Since 2016, the SOHN conference alone has raised over $10m, while in March 2020, Hearts and Minds distributed $9 million in donations to their beneficiaries.